2009
DOI: 10.1248/bpb.32.527
|View full text |Cite
|
Sign up to set email alerts
|

Pharmaceutically Important Pre- and Posttranslational Modifications on Human Serum Albumin

Abstract: Recombinant technology allows engineering and production of proteins with desirable properties. Human serum albumin has been developed with recombinant technology, and thus plays an increasing role as a drug carrier in the clinical setting. Genetic variations usually occur on the surface of the protein, and do not impose significant effects on the conformation of albumin. However, binding of fatty acids by genetic variants is affected according to the location of the mutation. Albumin undergoes three major pos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
44
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 48 publications
(44 citation statements)
references
References 90 publications
(90 reference statements)
0
44
0
Order By: Relevance
“…Albumin is widely used in clinical settings as a biomaterial for medical and pharmaceutical applications because of its availability, biodegradability, lack of toxicity, and non-immunogenicity. 51,52 Thus, our studies may not only bring new insights into the pathogenesis of FAP, but also suggest novel therapeutic strategies for FAP.…”
Section: Discussionmentioning
confidence: 93%
“…Albumin is widely used in clinical settings as a biomaterial for medical and pharmaceutical applications because of its availability, biodegradability, lack of toxicity, and non-immunogenicity. 51,52 Thus, our studies may not only bring new insights into the pathogenesis of FAP, but also suggest novel therapeutic strategies for FAP.…”
Section: Discussionmentioning
confidence: 93%
“…Human serum albumin (HSA) is a single polypeptide consisting of 585 amino acids, including 35 cysteines and 17 disulfide bridges (104). In human plasma, S-nitroso-serum albumin (SNO-SA) accounts for an impressive 82% of all Snitrosothiols; thus, it follows that the single free cysteine (Cys34) (pKa = *5) is observed to be highly reactive with nitrogen oxide species (126).…”
Section: Human Serum Albuminmentioning
confidence: 99%
“…In concert with progress in genetic engineering, physicochemical characterization methods for proteins in microscale HSA have also developed substantially, although posttranslational modifications remain a bottleneck in such characterizations. 1) HSA is a globular monomeric protein with a molecular weight of 66.5 kDa, and contains 35 cysteinyl residues, 34 of which participate in 17 disulfide bridges.…”
mentioning
confidence: 99%